D Kelly1, E Theodoratou2, S M Farrington3,4, R Fraser2, H Campbell2,3,4, M G Dunlop3,4, L Zgaga1,2. 1. Department of Public Health and Primary Care, Trinity College Dublin, Dublin, Ireland. 2. Centre for Population Health Sciences, University of Edinburgh, Edinburgh, EH8 9AG, U.K. 3. Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, U.K. 4. MRC Human Genetics Unit, Western General Hospital Edinburgh, Edinburgh, EH4 2XU, U.K.
Abstract
BACKGROUND: Solar ultraviolet B (UVB) radiation is the major source of vitamin D (vitD) for humans. OBJECTIVES: To describe ambient UVB radiation at wavelengths that induce vitD synthesis (vitD-UVB) in Scotland, and to examine the relationship to serum 25-hydroxyvitamin D (25OHD). METHODS: We estimated the average vitD-UVB dose for each day of the year and for each postcode area in Scotland, using the Tropospheric Emission Monitoring Internet Service database. Cumulative and weighted vitD-UVB (CW-vitD-UVB) exposure at place of residence was calculated for each participant. Plasma 25OHD was assayed in 1964 healthy participants. RESULTS: Significant seasonal and geographical variation in vitD-UVB was observed. Ambient vitD-UVB exposure at place of residence was significantly associated with plasma 25OHD (P < 0·01). An average increase in 25OHD of 1 ng mL(-1) was observed for every 1000 mJ cm(-2) higher CW-vitD-UVB dose or for every 2·5 μg of daily supplement taken. Adequate 25OHD concentration (> 16 ng mL(-1)) was observed in the majority when CW-vitD-UVB dose was > 6000 mJ cm(-2), a level of ambient radiation achieved only in summer months in Scotland. When predicting vitD deficiency, dramatic improvement in the area under the curve was observed (from 0·55 to 0·70) after CW-vitD-UVB dose was added to the model, in addition to a range of other covariates. CONCLUSIONS: Ambient vitD-UVB can be a useful predictor of vitD status. Geotemporally mapped measurements of vitD-UVB can be used as a proxy for vitD status or as a covariate in epidemiological research, particularly if 25OHD is unavailable.
BACKGROUND: Solar ultraviolet B (UVB) radiation is the major source of vitamin D (vitD) for humans. OBJECTIVES: To describe ambient UVB radiation at wavelengths that induce vitD synthesis (vitD-UVB) in Scotland, and to examine the relationship to serum 25-hydroxyvitamin D (25OHD). METHODS: We estimated the average vitD-UVB dose for each day of the year and for each postcode area in Scotland, using the Tropospheric Emission Monitoring Internet Service database. Cumulative and weighted vitD-UVB (CW-vitD-UVB) exposure at place of residence was calculated for each participant. Plasma 25OHD was assayed in 1964 healthy participants. RESULTS: Significant seasonal and geographical variation in vitD-UVB was observed. Ambient vitD-UVB exposure at place of residence was significantly associated with plasma 25OHD (P < 0·01). An average increase in 25OHD of 1 ng mL(-1) was observed for every 1000 mJ cm(-2) higher CW-vitD-UVB dose or for every 2·5 μg of daily supplement taken. Adequate 25OHD concentration (> 16 ng mL(-1)) was observed in the majority when CW-vitD-UVB dose was > 6000 mJ cm(-2), a level of ambient radiation achieved only in summer months in Scotland. When predicting vitD deficiency, dramatic improvement in the area under the curve was observed (from 0·55 to 0·70) after CW-vitD-UVB dose was added to the model, in addition to a range of other covariates. CONCLUSIONS: Ambient vitD-UVB can be a useful predictor of vitD status. Geotemporally mapped measurements of vitD-UVB can be used as a proxy for vitD status or as a covariate in epidemiological research, particularly if 25OHD is unavailable.
Authors: Ibrahim M Kaddam; Adnan M Al-Shaikh; Bahaa A Abaalkhail; Khalid S Asseri; Yousef M Al-Saleh; Ali A Al-Qarni; Ahmed M Al-Shuaibi; Waleed G Tamimi; Abdelmoneim M Mukhtar Journal: Saudi Med J Date: 2017-04 Impact factor: 1.484
Authors: Mark A Little; Lina Zgaga; Jennifer Scott; Enock Havyarimana; Albert Navarro-Gallinad; Arthur White; Jason Wyse; Jos van Geffen; Michiel van Weele; Antonia Buettner; Tamara Wanigasekera; Cathal Walsh; Louis Aslett; John D Kelleher; Julie Power; James Ng; Declan O'Sullivan; Lucy Hederman; Neil Basu Journal: Arthritis Res Ther Date: 2022-06-18 Impact factor: 5.606
Authors: P G Vaughan-Shaw; F O'Sullivan; S M Farrington; E Theodoratou; H Campbell; M G Dunlop; L Zgaga Journal: Br J Cancer Date: 2017-03-16 Impact factor: 7.640
Authors: Giancarlo Isaia; Henri Diémoz; Francesco Maluta; Ilias Fountoulakis; Daniela Ceccon; Alcide di Sarra; Stefania Facta; Francesca Fedele; Giuseppe Lorenzetto; Anna Maria Siani; Gianluca Isaia Journal: Sci Total Environ Date: 2020-11-20 Impact factor: 7.963